Page last updated: 2024-08-26

selenium and sorafenib

selenium has been researched along with sorafenib in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Chen, T; Huang, X; Li, C; Lin, W; Lin, X; Yang, F; Zheng, L1
Abdel-Hamed, AR; Abo-Elmatty, DM; Abulsoud, AI; Al-Noshokaty, TM; Mesbah, NM1
Fan, SY; He, LJ; Jia, YL; Li, S; Nan, X; Pei, XT; Wang, DX; Wang, HY; Wang, XK; Xi, JF; Xu, YC; Yue, W; Zeng, Q; Zhang, B; Zhang, M; Zhang, MM; Zhong, W; Zhou, JN; Zhou, XB1
Goltyaev, MV; Gudkov, SV; Simakin, AV; Turovsky, EA; Varlamova, EG1
Gudkov, SV; Khabatova, VV; Turovsky, EA; Varlamova, EG1

Other Studies

5 other study(ies) available for selenium and sorafenib

ArticleYear
Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy.
    Biomaterials, 2019, Volume: 216

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoradiotherapy; Delayed-Action Preparations; Female; Humans; Hydrogels; Liver Neoplasms; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Nanoparticles; Selenium; Sorafenib

2019
Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis.
    Life sciences, 2022, Aug-15, Volume: 303

    Topics: Animals; Antineoplastic Agents; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Glypicans; Liver Neoplasms; Mammals; Nanoparticles; NF-kappa B; Proto-Oncogene Proteins c-akt; Rats; RNA, Long Noncoding; Selenium; Sorafenib; Thioacetamide; TOR Serine-Threonine Kinases

2022
A Functional Screening Identifies a New Organic Selenium Compound Targeting Cancer Stem Cells: Role of c-Myc Transcription Activity Inhibition in Liver Cancer.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:22

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Early Detection of Cancer; Liver Neoplasms; Mice; Molecular Docking Simulation; Neoplastic Stem Cells; Selenium; Selenium Compounds; Sorafenib

2022
Comparative Analysis of the Cytotoxic Effect of a Complex of Selenium Nanoparticles Doped with Sorafenib, "Naked" Selenium Nanoparticles, and Sorafenib on Human Hepatocyte Carcinoma HepG2 Cells.
    International journal of molecular sciences, 2022, Jun-14, Volume: 23, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Nanoparticles; Selenium; Sorafenib

2022
Ca
    International journal of molecular sciences, 2023, Jan-26, Volume: 24, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Astrocytes; Cell Line, Tumor; Glioblastoma; Humans; Niacinamide; Phenylurea Compounds; Selenium; Sorafenib

2023